Fibrocystic breast changes lead to the development of fluid-filled round or oval sacs cysts and more prominent scar-like fibrous tissue, which can make breasts feel tender, lumpy or ropy. Fibrocystic breasts are composed of tissue that feels lumpy or rope-like in texture. Doctors call this nodular or glandular breast tissue. It's not at all uncommon to have fibrocystic breasts.
Fibrocystic breast disease - FAQ | University of Iowa Hospitals & Clinics
About half of women develop them fibrocystic breast changes at some point in their lives. While fibrocystic breast tissue can be painful and feature lumpy or rope-like textures, which may cause concern, these changes are completely healthy. The benign condition is neither a symptom of nor a risk factor for breast cancer. This used to be referred to as "fibrocystic breast disease," but doctors are now more likely to call it simply "fibrocystic breasts" or "fibrocystic breast changes," as the condition is not something that is harmful. The primary symptom of fibrocystic breast tissue is its lumpy, rope-like texture. If you were to look at fibrocystic tissue under a microscope, you would likely see several components that contribute to this, including:.
Fibrocystic breast disease - FAQ
The pathophysiology of fibrocystic breast disease is determined by estrogen predominance and progesterone deficiency that result in hyperproliferation of connective tissue fibrosis , which is followed by facultative epithelial proliferation; the risk of breast cancer is increased twofold to fourfold in these patients. The clinical correlate of fibrocystic disease is reflected by breast and axillary pain or tenderness in response to development of fibrocystic plaques, nodularity, macrocysts, and fibrocystic lumps. The disease progresses with advancing premenopausal age and is most pronounced in women during their 40s. Fibrocystic changes regress during the postmenopausal period. Medical treatment of fibrocystic disease is accomplished: by suppression of ovarian estrogen secretion with a low-estrogen oral contraceptive, whereby the action of estrogen on breast tissues is opposed by the oral contraceptive's progestin component nortestosterone derivatives , or by cyclic administration of a progestogen progesterone, medroxyprogesterone acetate that modulates the mammary effects of estrogen.
Fibrocystic breast changes is a condition of the breasts where there may be pain , breast cysts , and breast masses. Risk factors include an early age at first menstrual period and either having children late or not having children. Management may involve education about the condition, a well fitting bra , and pain medication. The changes in fibrocystic breast disease are characterised by the appearance of fibrous tissue and a lumpy, cobblestone texture in the breasts. These lumps are smooth with defined edges, and are usually free-moving in regard to adjacent structures.